DE69129267D1 - Methode zur behandlung intestinaler krankheiten - Google Patents

Methode zur behandlung intestinaler krankheiten

Info

Publication number
DE69129267D1
DE69129267D1 DE69129267T DE69129267T DE69129267D1 DE 69129267 D1 DE69129267 D1 DE 69129267D1 DE 69129267 T DE69129267 T DE 69129267T DE 69129267 T DE69129267 T DE 69129267T DE 69129267 D1 DE69129267 D1 DE 69129267D1
Authority
DE
Germany
Prior art keywords
intestinal diseases
treating intestinal
igf
disorders
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69129267T
Other languages
English (en)
Other versions
DE69129267T2 (de
Inventor
Francis John Ballard
Leanna Christine Read
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Gropep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3774495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69129267(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gropep Ltd filed Critical Gropep Ltd
Application granted granted Critical
Publication of DE69129267D1 publication Critical patent/DE69129267D1/de
Publication of DE69129267T2 publication Critical patent/DE69129267T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DE69129267T 1990-02-13 1991-01-30 Methode zur behandlung intestinaler krankheiten Expired - Lifetime DE69129267T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ858690 1990-02-13
PCT/AU1991/000031 WO1991012018A1 (en) 1990-02-13 1991-01-30 Method for treating intestinal diseases

Publications (2)

Publication Number Publication Date
DE69129267D1 true DE69129267D1 (de) 1998-05-20
DE69129267T2 DE69129267T2 (de) 1998-09-10

Family

ID=3774495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129267T Expired - Lifetime DE69129267T2 (de) 1990-02-13 1991-01-30 Methode zur behandlung intestinaler krankheiten

Country Status (5)

Country Link
EP (1) EP0515434B1 (de)
AT (1) ATE165008T1 (de)
CA (1) CA2074166C (de)
DE (1) DE69129267T2 (de)
WO (1) WO1991012018A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234439A (en) * 1990-07-10 1997-08-22 Pharmacia & Upjohn Ab Use of igf-1 to reduce fetal growth retardation in non human mammals
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
AU670951B2 (en) * 1992-06-08 1996-08-08 Chiron Corporation Use of growth factor IGF-I and/or IGF-II
NZ260309A (en) * 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
AU5863396A (en) * 1995-06-02 1996-12-18 Harbor-Ucla Research And Education Institute Insulin suppression test with igf
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
ATE463252T1 (de) 2000-08-29 2010-04-15 Aurogen Inc Methode zur behandlung des zentralnervensystems durch applikation von strukturanaloga von igf
EP1750755A1 (de) * 2004-06-02 2007-02-14 Technion Research And Development Foundation, Ltd. Verfahren und formulierungen zur erhöhung der darmfunktion
WO2007014167A2 (en) * 2005-07-22 2007-02-01 Five Prime Therapeutics, Inc. Compositions for and methods of treating epithelial diseases with growth factors
KR102245539B1 (ko) 2018-02-12 2021-04-29 주식회사 지앤피바이오사이언스 코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703625D0 (sv) * 1987-09-18 1987-09-18 Kabivitrum Ab New medical use
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド
DE69021335T2 (de) * 1989-06-09 1996-04-11 Gropep Pty. Ltd., Adelaide Wachstumshormonfusionsproteine.
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor

Also Published As

Publication number Publication date
ATE165008T1 (de) 1998-05-15
EP0515434B1 (de) 1998-04-15
EP0515434A4 (en) 1993-06-16
EP0515434A1 (de) 1992-12-02
CA2074166A1 (en) 1991-08-14
DE69129267T2 (de) 1998-09-10
WO1991012018A1 (en) 1991-08-22
CA2074166C (en) 2003-11-25

Similar Documents

Publication Publication Date Title
DE69324117D1 (de) Verfahren zur Behandlung von Knochengeweben und implantierbare Biomaterialien dafür
DE69129267D1 (de) Methode zur behandlung intestinaler krankheiten
ATE136753T1 (de) Methode zur beseitigung von infektionserregern in geweben
DE69637800D1 (de) Verbindungen zur Behandlung der ischaemischen Gewebe
DE3888273D1 (de) Medizinischer Apparat zur Behandlung mit Ultraschall.
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69322957D1 (de) L - Deprenyl zur Behandlung von makulärer Degeneration
DE69025922D1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
RU93054017A (ru) Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
DE3483931D1 (de) Wachstumshormone freisetzende peptiden und methode fuer die behandlung von saeugetieren.
ATE377026T1 (de) Behandlung von fettleibigkeit
ATE260107T1 (de) Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis
ATE326534T1 (de) Methode zur behandlung von muskelkrankheiten
NO975360L (no) Peptid som inhiberer forhöyede triglyseridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent
DE69119865D1 (de) Einrichtung zur medizinischen Behandlung
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE183651T1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE192656T1 (de) Verfahren zur behandlung von patienten mit chronischer lebererkrankung
ATE246511T1 (de) Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndroms
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE69433687D1 (de) Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz
DE3865283D1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA AU LTD., ADELAIDE, AU

8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA DK A/S, BAGSVAERD, DK

8328 Change in the person/name/address of the agent

Representative=s name: SPLANEMANN PATENT- UND RECHTSANWAELTE PARTNERSCHAF